Inflammatix Revenue and Competitors
Estimated Revenue & Valuation
- Inflammatix's estimated annual revenue is currently $18.3M per year.
- Inflammatix's estimated revenue per employee is $155,000
- Inflammatix's total funding is $137.8M.
Employee Data
- Inflammatix has 118 Employees.
- Inflammatix grew their employee count by -12% last year.
Inflammatix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | VP Strategy & Corporate Development | Reveal Email/Phone |
3 | VP Engineering | Reveal Email/Phone |
4 | VP, Marketing | Reveal Email/Phone |
5 | VP Machine Learning | Reveal Email/Phone |
6 | Head Talent Acquisition (Fractional) | Reveal Email/Phone |
7 | VP Computational Biology | Reveal Email/Phone |
8 | VP Operations | Reveal Email/Phone |
9 | Co-Founder and Chief Business Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Inflammatix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Inflammatix?
Inflammatix, Inc. is a venture-backed startup located in the San Francisco Bay Area that is building novel diagnostics for acute infections and sepsis based on our unique immune biomarkers. Approximately $10 billion / year is spent trying to diagnose acute infections, but current technologies that focus on ￃﾢ￢ﾂﾬￋﾜfinding the bugￃﾢ￢ﾂﾬ￢ﾄﾢ are (1) slow and (2) effective in fewer than 30% of cases. Inflammatixￃﾂￂﾠhas developed a statistically rigorous,ￃﾂￂﾠextensively validated diagnostic method that 'reads' the immune system. Our HostDxￃﾢ￢ﾀﾞￂﾢ tests report clinically actionable information on theￃﾂￂﾠpresence, type (bacterial or viral), and severity of infection in all patients. They have been extensively validated and published in top-tier medical journals. After this initial product, Inflammatix plans to develop and commercialize additional novel diagnostic tests to address significant unmet clinical needs.
keywords:Biotechnology, Medical Devices, Diagnostics, Bioinformatics
$137.8M
Total Funding
118
Number of Employees
$18.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Inflammatix News
Inflammatix, a pioneering molecular diagnostics company, announced today a contract extension of $12.1 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and ...
Inflammatix secured $102 million in new financing to help commercialize its point-of-care diagnostics portfolio aimed at profiling a person’s immune response to quickly ascertain bacterial and viral infections and help curb potential antimicrobial resistance. According to Inflammatix, worldwide ...
Inflammatix, a Burlingame, Calif.-based molecular diagnostics company delivering precision medicine at the point of care, raised $32m in Series C financing. The round included participation from existing investors Khosla Ventures, Northpond Ventures and Think.Health Ventures, and new investors ...
Other Companies in Burlingame
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.6M | 119 | -5% | N/A |
#2 | $17.8M | 127 | 49% | $27.2M |
#3 | $19.7M | 127 | -18% | $62.1M |
#4 | $15M | 134 | 6% | N/A |
#5 | $30.6M | 135 | 7% | $26M |